Browse Articles

Discover research articles across all indexed journals

Engineering a dual-antigen mRNA vaccine to restore immune control in chronic hepatitis B

Nature Communications Baowen Zhang, Yiyuan Wang, Da Chen et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74006-y

Ocean ‘cold blob’ is evidence for a troubling climate trend

Nature Jun 18, 2026 DOI: 10.1038/d41586-026-01826-9

Author Correction: Forecasting the dissemination of antibiotic resistance genes across bacterial genomes

Nature Communications Morten O. A. Sommer, Christian Munck Jun 18, 2026 DOI: 10.1038/s41467-026-74295-3

A meta-analysis of infant gut viromes reveals global patterns in bacteriophage community assembly and functional capacity over the first three years of life

Nature Communications Michael Shamash, Corinne F. Maurice Jun 18, 2026 DOI: 10.1038/s41467-026-74609-5

Abstract Assembly of the gut microbiota in infancy is an important health determinant, yet the viral component, the virome, remains poorly described. Here, we conduct a meta-analysis of 12 infant cohorts across 8 countries to model gut virome development over the first three years of life. Our results revealed distinct diversity patterns, where viral richness increased significantly over the first eight months of life alongside a loss of community evenness. We define virome developmental velocity, the rate of change between sequential samples, which significantly decreased over time. This was mirrored by community-wide convergence, as infant viromes became more similar with age. Functionally, the transition to a stable state involved a significant decrease in extracellular temperate phages and shifts in phage-encoded auxiliary metabolic genes, which can modulate host metabolism. Our work provides a baseline characterization of gut virome development, marked by a conserved successional trajectory, providing a framework to identify disease-associated perturbations.

Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia

Blood Lili Ren, Honghai Zhang, Olga Bobileva et al. Jun 18, 2026 DOI: 10.1182/blood.2025030336

Abstract N7-methylguanosine (m7G), a prevalent modification in transfer RNAs (tRNAs), is primarily catalyzed by the methyltransferase METTL1. Although growing evidence supports a role for METTL1 in various tumors, its therapeutic potential and precise function in leukemia stem cell (LSC) homeostasis remain largely unexplored. Here, we identify METTL1 as a key regulator of LSC self-renewal and homing within bone marrow (BM) microenvironment through catalyzing m7G formation on a specific tRNA, tRNAPheGAA, thereby promoting leukemogenesis. Mechanistically, METTL1 loss significantly reduces m7G abundance and steady-state levels of tRNAPheGAA, leading to translation suppression and degradation of transcripts enriched with tRNAPheGAA-related codons, such as hematopoietic cell kinase (HCK). Decreased HCK expression disrupts CXCR4 signaling, impairing LSC self-renewal and BM homing. Therapeutically, we characterized a small-molecule METTL1 inhibitor (M1i; NSC137443), through high-throughput screening. Pharmacological inhibition of METTL1 demonstrated potent antitumor efficacy by reducing tRNA m7G levels and disrupting the tRNAPheGAA/HCK/CXCR4 cascade. Notably, targeting METTL1 significantly reduces LSC frequency, delays leukemogenesis, and prolongs survival in multiple acute myeloid leukemia models. Together, our findings establish a previously unrecognized role for METTL1 and its target tRNAPheGAA in LSC homeostasis and provide compelling proof-of-concept evidence that METTL1 is a druggable epitranscriptomic target for antileukemia therapy.

Early neonatal mortality and its associated factors at Doctor Bogalech Gebre Memorial General Hospital, Central Ethiopia: A cross-sectional study

Scientific Reports Desalegn Berhanu Katiso, Tariku Laelago Ersado, Mesfin Menza Jaldo et al. Jun 18, 2026 DOI: 10.1038/s41598-026-57366-9

Attaining 19.12% solar cell efficiency for non-fused ring electron acceptors via multi-dimensional charge transport

Nature Communications Miao Li, Qianqian Zhu, Nan Wei et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74509-8

Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial

Blood Moritz Fürstenau, Carsten U. Niemann, Sandra Robrecht et al. Jun 18, 2026 DOI: 10.1182/blood.2025032160

Abstract Fixed-duration venetoclax combinations have become a standard first-line treatment in chronic lymphocytic leukemia (CLL). The phase 3 CLL13/GAIA trial assesses 3 time-limited combinations: venetoclax-rituximab (RV), venetoclax-obinutuzumab (GV), and venetoclax-obinutuzumab-ibrutinib (GIV), in comparison with chemoimmunotherapy (CIT). Fit patients with CLL without TP53 aberrations were randomized between 6 cycles of CIT (fludarabine-cyclophosphamide-rituximab [FCR] or bendamustine-rituximab [BR]) or 12 cycles of RV, GV, or GIV (GIV: ibrutinib continuation until cycle 36 if measurable residual disease at months 12/15). In total, 926 patients were randomized (GIV: 231, GV: 229, RV: 237, and CIT: 229 [FCR: 150, BR: 79]). With a median observation time of 63.8 months, 5-year progression-free survival (PFS) rates were 81.3% (GIV), 69.8% (GV), 57.4% (RV), and 50.7% (CIT). PFS was superior for GV and GIV compared with CIT and RV (P< .001 in each case). In addition, GIV showed longer PFS than GV (P = .0046). Venetoclax-based re-treatment after venetoclax-based first-line regimens was efficacious, with 2-year treatment-free survival >80% from second-line treatment. No differences in overall survival were observed between treatment arms (5-year rates: GIV, 94.3%; GV, 93.6%; RV, 94.7%; and CIT, 90.7%). The incidence rates of severe infections were highest with CIT, whereas cardiac events were most frequent with GIV. Compared with patients treated with CIT, those treated with GV or RV reported rapid and significantly greater quality-of-life (QoL) improvements. In the GIV arm, clinically relevant QoL improvements occurred later (month 15, after the end of treatment in most patients) than with GV/RV, likely due to a higher treatment-related symptom burden. This trial was registered at www.clinicaltrials.gov as NCT02950051.

Integrated application of humic acid, urea, and microalgal biostimulant enhances drought tolerance in pea (Pisum sativum L.)

Scientific Reports Ahmed Alsawaf, Shakir Mahmood Saied, Omar Ahmed Fathi Al-Rubaie et al. Jun 18, 2026 DOI: 10.1038/s41598-026-58542-7

Electron-ion equilibration in superheated gold

Nature Communications Travis D. Griffin, Dirk O. Gericke, Daniel Haden et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74346-9

Abstract Electron-ion equilibration dynamics in samples driven into superheated states with multi-eV electron temperatures represent a fundamental process in nonequilibrium physics. A clear picture of the evolving ion temperature is essential for understanding the strength of the electron-ion coupling. However, direct, model-independent measurements of the ion temperature in laser-irradiated samples have remained experimentally elusive. Using inelastic X-ray scattering with meV-resolution in gold samples, the ion response to ultrafast heating by the hot electrons can be resolved, quantifying the electron-ion equilibration dynamics. We report measurements revealing a strongly enhanced energy transfer rate compared to that in weakly excited gold. Moreover, we obtain a quasi-constant electron-ion coupling at the highly elevated electron temperatures. These results place new constraints on electron-ion energy transfer in warm dense matter and establish a path toward quantitative benchmarking of models for nonequilibrium dynamics.

Pathogenic role of serpin B3-positive neutrophils in reinforcing thrombus stiffening during ischemic stroke

Blood Jiankun Zang, Aijun Lu, Bing Yang et al. Jun 18, 2026 DOI: 10.1182/blood.2025029516

Abstract The contribution of immune cells to thrombus architecture and mechanical properties in acute ischemic stroke (AIS) remains poorly understood. Using 3-dimensional imaging and multiplex staining, we mapped immune cells in human stroke thrombi and identified neutrophils as the dominant population. Analysis of 19 thrombi confirmed their positive correlation with collagen, increased stiffness, and poorer clinical outcomes. To preserve spatial context, we developed a laser capture–based proteomic workflow and analyzed thrombus neutrophils from 34 patients with AIS stratified by 90-day outcomes, followed by validation in an independent cohort of 22 patients. Proteomic analysis revealed serpin B3 as a neutrophil-enriched protein strongly correlated with poor prognosis. In murine models of ferric chloride–induced carotid artery thrombosis and middle cerebral artery occlusion, experiments using wild-type, neutrophil-depleted, and Serpinb3a knockout mice demonstrated that neutrophil-derived serpin B3 promotes early thrombus formation, enhances collagen deposition, and contributes to progressive thrombus stiffening. Mechanistically, serpin B3 secreted by neutrophils amplifies thrombus stiffness through upregulation of transforming growth factor β1, neutrophil extracellular traps, and COL1A1. Targeted Serpinb3a knockdown delayed vascular occlusion, improved thrombolysis efficiency, and resulted in better neurological recovery. Collectively, these findings identify a neutrophil-driven mechanism underlying thrombus stiffening and establish SERPINB3 as both a prognostic biomarker and a promising therapeutic target in AIS. This project has been registered with the Chinese Clinical Trial Registration Platform (https://www.chictr.org.cn/index.html) and has successfully passed the review process (registration number: ChiCTR2300077911).

Design and simulation of a hybrid PLC–AI automotive control module for adaptive lighting and honking

Scientific Reports Yogesh Patil, Rachana Patil, Rucha Shinde et al. Jun 18, 2026 DOI: 10.1038/s41598-026-58882-4

Why are so many young people getting cancer? What researchers do and don’t know

Nature Heidi Ledford Jun 18, 2026 DOI: 10.1038/d41586-026-01780-6

Sub-femtosecond figure-of-merit millimeter-wave switches via solution-processed MoS2 for 6G radio-frequency front-ends

Nature Communications Changwoo Pyo, Sungmoon Park, Seungchan Lee et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74534-7

Signal AML stem cells to home: written and sent by METTL1

Blood Diu T. T. Nguyen Jun 18, 2026 DOI: 10.1182/blood.2026033731

Abdominal fat distribution phenotypes and metabolic risk in premenopausal Asian women: insights beyond general adiposity measures

Scientific Reports Yeshe M. Kway, Navin Michael, Narasimhan Kothandaraman et al. Jun 18, 2026 DOI: 10.1038/s41598-026-55520-x

Programmable microwave cluster states via Josephson metamaterials

Nature Communications A. Alocco, A. Celotto, E. Palumbo et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74377-2

Abstract Cluster states are a fundamental resource for continuous-variable quantum computing, enabling measurement-based protocols that can scale beyond the limitations of qubit-based architectures. Here, we demonstrate on-demand generation of multimode entangled microwave cluster states using a programmable Josephson Traveling-Wave Parametric Amplifier (JTWPA) operated in the three-wave mixing regime. By injecting a tailored, non-equidistant set of pump tones via an arbitrary waveform generator, we engineer frequency-specific nonlinear couplings between multiple frequency modes. The entanglement structure is verified via frequency-resolved heterodyne detection of quadrature nullifiers, confirming the target graph topology of the cluster state. Our approach allows reconfigurability through the pumps spectrum and supports scalability by leveraging the wide bandwidth and spatial homogeneity of the JTWPA. This platform opens new avenues for scalable measurement-based quantum information processing in the microwave domain, compatible with superconducting circuit architectures.

Immune-mediated side effects of cancer immunotherapies

Blood Lukas M. Braun, Jarushka Naidoo, Robert Zeiser Jun 18, 2026 DOI: 10.1182/blood.2025030059

Abstract Immunotherapies, such as allogeneic hematopoietic cell transplantation and infusion of chimeric antigen receptor (CAR) T cells have significantly extended our therapeutic armamentarium against several hematologic malignancies. Blocking negative regulators of immunity with immune checkpoint inhibitors has significantly improved the survival of patients with mainly solid tumors. Despite their beneficial effects, these therapies are also associated with severe, immune-mediated side effects. Here, we discuss biological similarities and differences of acute graft-versus-host disease (GVHD), cytokine release syndrome, immune effector cell–associated neurotoxicity syndrome, immune effector cell–associated hemophagocytic lymphohistiocytosis–like syndrome, immune effector cell–associated hematotoxicity, local immune effector cell–associated toxicity syndrome, and immune-related adverse events after immune checkpoint inhibition (irAEs). Recent data have led to a better understanding of the role of myeloid cells and T cells, including tissue-resident T cells, in the pathophysiology of GVHD, CAR T-cell–associated immunotoxicities, and irAEs. Furthermore, we summarize approved, currently evaluated, and potential future therapies for immune-mediated toxicities of cancer immunotherapies. This review will help to understand how therapeutic strategies target communalities of different side effects to overcome immune-mediated side effects of cancer immunotherapies.

Physics-informed convolutional neural networks for fluid flow through porous media

Scientific Reports Rafał Topolnicki, Paweł Dłotko, Maciej Matyka Jun 18, 2026 DOI: 10.1038/s41598-026-55389-w

Abstract Accurate simulation of fluid flow in porous media is a challenging task due to the complexity of pore-space geometries and the computational cost of solving the Navier–Stokes equations. Traditional numerical solvers rely on carefully constructed meshes, often requiring manual intervention, and typically exhibit slow convergence. This difficulty is particularly pronounced in porous media, where the diffusive nature of momentum transport is hindered by intricate solid boundaries. These challenges limit the efficiency of numerical simulations, particularly when repeated evaluations are required. We present a neural-network-based framework for predicting pore-scale velocity fields directly from sample geometry. The method is based on a convolutional encoder–decoder architecture with skip connections, designed to preserve fine-grained structural information. Physical consistency is encouraged through a custom loss function composed of multiple terms: incompressibility, no-flow conditions within solids, periodicity constraints, and agreement with the global tortuosity index. We systematically analyze the influence of weight selection for these loss terms, quantifying their individual contributions to prediction accuracy. Several architectural variants inspired by computer vision are evaluated to identify one providing the best performance and robustness. The generalization ability of the trained network is assessed on samples outside the training distribution, including variations in boundary conditions, obstacle geometry, and porosity. Finally, we demonstrate additional practical applications in which network predictions are used to initialize the Lattice–Boltzmann simulations, a standard fluid dynamics solver, often used in complex boundary problems like porous media and used by us to train the network. We have used network-generated velocity field as a starting point and found that this significantly accelerates LBM solver convergence, achieving improvements in over 90% of cases.

A Bacillales-specific tubular scaffold essential for NADH dehydrogenase activity

Nature Communications Farida Seduk, Rayan Osman, Pierre Simon Garcia et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74385-2

Abstract Respiratory type II NADH:quinone oxidoreductases (NDH-II) are typically monotopic flavoproteins that make direct contact with the membrane to access the quinone pool. Here, we show that in Bacillus subtilis , one NDH-II, termed Ndh, assembles with the helical membrane plugin (HMP) protein YjlC and forms supramolecular fibers. Genetic and biochemical analyses demonstrate that Ndh and YjlC proteins are essential for NADH oxidation. Cryo-EM analysis reveals that YjlC forms a tubular scaffold onto which multiple Ndh subunits are regularly docked via their C-terminal domain, repurposed from its classical role in direct membrane binding. These fibers can extend up to ~1000 Å, creating a continuous hydrophobic tunnel filled with lipids and quinones, thereby mimicking the membrane environment. Comparative genomics unveils that this partnership arose exclusively within Bacillales through the recruitment of an ancestral HMP originally associated with sulfide:quinone reductases. Together, our findings uncover a lineage-specific structural adaptation in which NDH-II enzymes depend on an HMP scaffold, expanding their functional diversity beyond the classical monotopic paradigm.